Targeting EGFR and WNTand#946; catenin pathway to monitor and sensitize CSC mediated therapy resistance in Head and Neck Cancer

Abstract

Abstract is available newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced